145 related articles for article (PubMed ID: 24603157)
1. High-density lipoprotein functionality in coronary artery disease.
Kosmas CE; Christodoulidis G; Cheng JW; Vittorio TJ; Lerakis S
Am J Med Sci; 2014 Jun; 347(6):504-8. PubMed ID: 24603157
[TBL] [Abstract][Full Text] [Related]
2. HDL-C: role as a risk modifier.
Barter P
Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
[TBL] [Abstract][Full Text] [Related]
3. Should we routinely measure low-density and high-density lipoprotein subclasses?
Rizzo M; Berneis K; Zeljkovic A; Vekic J
Clin Lab; 2009; 55(11-12):421-9. PubMed ID: 20225664
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.
Khera AV; Cuchel M; de la Llera-Moya M; Rodrigues A; Burke MF; Jafri K; French BC; Phillips JA; Mucksavage ML; Wilensky RL; Mohler ER; Rothblat GH; Rader DJ
N Engl J Med; 2011 Jan; 364(2):127-35. PubMed ID: 21226578
[TBL] [Abstract][Full Text] [Related]
5. High-density lipoprotein and coronary heart disease: current and future therapies.
Natarajan P; Ray KK; Cannon CP
J Am Coll Cardiol; 2010 Mar; 55(13):1283-99. PubMed ID: 20338488
[TBL] [Abstract][Full Text] [Related]
6. HDL-A molecule with a multi-faceted role in coronary artery disease.
Arora S; Patra SK; Saini R
Clin Chim Acta; 2016 Jan; 452():66-81. PubMed ID: 26519003
[TBL] [Abstract][Full Text] [Related]
7. HDL particle functionality as a primary pharmacological target for HDL-based therapies.
Kypreos KE; Gkizas S; Rallidis LS; Karagiannides I
Biochem Pharmacol; 2013 Jun; 85(11):1575-8. PubMed ID: 23500547
[TBL] [Abstract][Full Text] [Related]
8. Relationship of low- and high-density lipoproteins to coronary artery plaque composition by CT angiography.
Nakazato R; Gransar H; Berman DS; Cheng VY; Lin FY; Achenbach S; Al-Mallah M; Budoff MJ; Cademartiri F; Callister TQ; Chang HJ; Chinnaiyan K; Chow BJ; Delago A; Hadamitzky M; Hausleiter J; Kaufmann P; Maffei E; Raff G; Shaw LJ; Villines TC; Dunning A; Cury RC; Feuchtner G; Kim YJ; Leipsic J; Min JK
J Cardiovasc Comput Tomogr; 2013; 7(2):83-90. PubMed ID: 23622503
[TBL] [Abstract][Full Text] [Related]
9. Newer therapeutic strategies to alter high-density lipoprotein level and function.
Bosch N; Frishman WH
Cardiol Rev; 2014; 22(1):17-24. PubMed ID: 23707991
[TBL] [Abstract][Full Text] [Related]
10. Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users.
Souza FR; Dos Santos MR; Porello RA; Fonseca GWPD; Sayegh ALC; Lima TP; Ferreira FD; Oliveira TF; Yonamine M; Takayama L; Pereira RMR; Negrão CE; Passarelli M; Rochitte CE; Alves MJNN
Atherosclerosis; 2019 Apr; 283():100-105. PubMed ID: 30826541
[TBL] [Abstract][Full Text] [Related]
11. Should low high-density lipoprotein cholesterol (HDL-C) be treated?
Toth PP; Barylski M; Nikolic D; Rizzo M; Montalto G; Banach M
Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):353-68. PubMed ID: 24840264
[TBL] [Abstract][Full Text] [Related]
12. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
Hausenloy DJ; Yellon DM
Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
[TBL] [Abstract][Full Text] [Related]
13. High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease.
Kratzer A; Giral H; Landmesser U
Cardiovasc Res; 2014 Aug; 103(3):350-61. PubMed ID: 24935432
[TBL] [Abstract][Full Text] [Related]
14. Ethnicity and coronary artery disease: the role of high-density lipoprotein - a change in paradigm.
Bravo K; Velarde GP
Expert Rev Cardiovasc Ther; 2015; 13(8):923-31. PubMed ID: 26159553
[TBL] [Abstract][Full Text] [Related]
15. Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease.
Krychtiuk KA; Kastl SP; Pfaffenberger S; Pongratz T; Hofbauer SL; Wonnerth A; Katsaros KM; Goliasch G; Gaspar L; Huber K; Maurer G; Dostal E; Oravec S; Wojta J; Speidl WS
Atherosclerosis; 2014 Dec; 237(2):589-96. PubMed ID: 25463093
[TBL] [Abstract][Full Text] [Related]
16. Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus.
Tan HC; Tai ES; Sviridov D; Nestel PJ; Ng C; Chan E; Teo Y; Wai DC
J Clin Lipidol; 2011; 5(6):467-73. PubMed ID: 22108150
[TBL] [Abstract][Full Text] [Related]
17. High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease.
Kosmas CE; Martinez I; Sourlas A; Bouza KV; Campos FN; Torres V; Montan PD; Guzman E
Drugs Context; 2018; 7():212525. PubMed ID: 29623098
[TBL] [Abstract][Full Text] [Related]
18. High density- and beta-lipoprotein screening for risk of coronary artery disease in the context of new findings on reverse cholesterol transport.
Levinson SS
Ann Clin Lab Sci; 2002; 32(2):123-36. PubMed ID: 12017193
[TBL] [Abstract][Full Text] [Related]
19. Modulation of high-density lipoproteins in a population in istanbul, Turkey, with low levels of high-density lipoproteins.
Mahley RW; Can S; Ozbayrakçi S; Bersot TP; Tanir S; Palaoğlu KE; Pépin GM
Am J Cardiol; 2005 Aug; 96(4):547-55. PubMed ID: 16098310
[TBL] [Abstract][Full Text] [Related]
20. Targeting high-density lipoproteins: update on a promising therapy.
Verdier C; Martinez LO; Ferrières J; Elbaz M; Genoux A; Perret B
Arch Cardiovasc Dis; 2013 Nov; 106(11):601-11. PubMed ID: 24074699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
